Literature DB >> 3244663

Formulation of vaccine adjuvant muramyldipeptides (MDP). 2. The thermal reactivity and pH of maximum stability of MDP compounds in aqueous solution.

M F Powell1, L C Foster, A R Becker, W Lee.   

Abstract

The degradation of muramyldipeptides (MDPs) in aqueous solution obeys the rate law kobs = kH+aH+ + ko + kHO-aHO- and the Arrhenius equation. For example, the rate constants for degradation of N-acetylmuramyl-L-threonyl-D-isoglutamine, 3, at 25 degrees C are kH+ = 2.3 X 10(-6) M-1 sec-1, ko = 8.2 X 10(-10) sec-1, and kHO- = 0.19 M-1 sec-1. The degradation rates are dependent on the side-chain substituents; it is predicted that sterically hindered MDP compounds will show an extended shelf life in aqueous solution. Product studies in the weakly acid pH region (where the pH of maximum stability occurs) show that MDP compounds degrade largely by hydrolysis of the dipeptide side chain. These data show that MDP 3 exhibits a shelf life (t90) of greater than 2 years in aqueous solutions of pH 4-4.5, the pH of maximum stability.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244663     DOI: 10.1023/a:1015929610687

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Adjuvant activity of synthetic cell-wall peptidoglycan subunits on monoazobenzenearsonate-N-acetyl-L-tyrosine and bacterial alpha-amylase in guinea pigs.

Authors:  I Azuma; K Sugimura; Y Yamamura; S Kusumoto; Y Tarumi
Journal:  Jpn J Microbiol       Date:  1976-02

2.  Formulation of vaccine adjuvant muramyldipeptides (MDP). 1. Characterization of amorphous and crystalline forms of a muramyldipeptide analogue.

Authors:  T W Chan; A Becker
Journal:  Pharm Res       Date:  1988-08       Impact factor: 4.200

Review 3.  Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.

Authors:  L Chedid; C Carelli; F Audibert
Journal:  J Reticuloendothel Soc       Date:  1979-12

4.  The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance.

Authors:  R Hunter; F Strickland; F Kézdy
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

5.  Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide).

Authors:  E E Ribi; J L Cantrell; K B Von Eschen; S M Schwartzman
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

Review 6.  An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity.

Authors:  A C Allison; N E Byars
Journal:  J Immunol Methods       Date:  1986-12-24       Impact factor: 2.303

7.  The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.

Authors:  C A Dinarello; R J Elin; L Chedid; S M Wolff
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

8.  The adjuvant activity of nonionic block polymer surfactants. III. Characterization of selected biologically active surfaces.

Authors:  R L Hunter; B Bennett
Journal:  Scand J Immunol       Date:  1986-03       Impact factor: 3.487

9.  Arthritis-inducing ability of a synthetic adjuvant, N-acetylmuramyl peptides, and bacterial disaccharide peptides related to different oil vehicles and their composition.

Authors:  O Kohashi; A Tanaka; S Kotani; T Shiba; S Kusumoto; K Yokogawa; S Kawata; A Ozawa
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

10.  The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers.

Authors:  R L Hunter; B Bennett
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

View more
  2 in total

1.  Formulation of vaccine adjuvant muramyldipeptides. 3. Processing optimization, characterization, and bioactivity of an emulsion vehicle.

Authors:  D M Lidgate; R C Fu; N E Byars; L C Foster; J S Fleitman
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

2.  Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B.

Authors:  Dongmei Lu; Lucila Garcia-Contreras; Ding Xu; Sherry L Kurtz; Jian Liu; Miriam Braunstein; David N McMurray; Anthony J Hickey
Journal:  Pharm Res       Date:  2007-07-27       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.